Montenegro anuncia redução de IRS nas rendas, isenção de mais-valias e maior dedução à coleta

[Ulisses Pereira]

"A Discouraging Up Market"

By Jim Cramer
RealMoney.com Columnist
1/7/2008 12:01 PM EST

Look, it's a crummy market. The stuff that is going up is just recession-proof stuff.

Pepsi's (PEP - commentary - Cramer's Take - Rating) the best example. Pepsi is all about making the numbers plus a penny.

Or Altria (MO - commentary - Cramer's Take - Rating). There was nothing new in that target bump. Didn't mean a thing. Just another good data point to talk about.

Rumors of BUD (BUD - commentary - Cramer's Take - Rating) being able to put through a price increase means a run to $55.

Lilly (LLY - commentary - Cramer's Take - Rating) and Abbott (ABT - commentary - Cramer's Take - Rating), no different. Same with J&J (JNJ - commentary - Cramer's Take - Rating) and Merck (MRK - commentary - Cramer's Take - Rating). Schering-Plough (SGP - commentary - Cramer's Take - Rating) should be ready to roll. I know I am betting that way.

Plus the Medco Health (MHS - commentary - Cramer's Take - Rating), which never quits in this environment.

Never.

I bet P&G can play catch-up. And keep an eye on Unilever (UN - commentary - Cramer's Take), that's breaking out, too.

Meanwhile, we are just seeing continuing degradation in Hewlett-Packard (HPQ - commentary - Cramer's Take - Rating), EMC (EMC - commentary - Cramer's Take - Rating) and all other hardware that is just all recession, too.

Again, discouraging.

Just discouraging.

At the time of publication, Cramer was long Altria, Schering-Plough, Hewlett-Packard and EMC. "

(in www.realmoney.com)